Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 24, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - May 24, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 24 of 24     Go To Page:

5/24/17 - GUEST COLUMN
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - How to lower your Medicare drug costs
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of AllerVarx? in the U.S. AllerVarx? is a clinically proven supplement,..
5/23/17 - DKSH and Boehringer Ingelheim improve access to treatment in Myanmar
DKSH and Boehringer Ingelheim improve access to treatment in Myanmar. DKSH, the leading Market Expansion Services provider with a focus on Asia, and Boehringer Ingelheim, one of the world's top 20 pharmaceutical companies, have signed an agreement to provide Myanmar patients better treatment options in vascular disease, arterial hypertension, cance
5/23/17 - Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks
The Health Care Sector which includes biotech, pharmaceutical and medical device stocks, continues to forge ahead despite recent concerns in the markets as some of the larger companies show attractive earnings growth potential all tied to new drug innovation, FDA approvals and device roll-outs. Health Care and Pharma stocks with developments and ma
5/23/17 - Medicare Q&A: Lower your Medicare drug costs
May is high season for California strawberries, and the fields were exploding with beautiful, ripe fruit. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug coverage m
5/23/17 - Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced a collaboration today with International Security Group to develop its ner
5/23/17 - Sunovion Announces Utibron? Neohaler (indacaterol/glycopyrrolate) Inhalation Powder Data Showing Lung Function and Health-Related Quality of Life Improvement in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sunovion Pharmaceuticals Inc. announced that multiple data analyses from two Phase 3 studies demonstrating that Utibron? Neohaler inhalation powder improved lung function, health-related quality of life, dyspnea and night-time symptoms compared to placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, were...
5/22/17 - Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%
By a News Reporter-Staff News Editor at Pharma Business Week Valeant Pharmaceuticals International, Inc.' s wholly owned subsidiary, Bausch+ Lomb, a leading global eye health company, announced that the U.S. Food and Drug Administration accepted the New Drug Application for brimonidine tartrate ophthalmic solution, 0.025%, and set a PDUFA action
5/22/17 - Innovus Pharma Signs Exclusive License and Distribution Agreement with Luminarie in Australia, New Zealand and the Philippines for Zestra for Female Sexual Arousal Disorder and Zestra Glide for Female Lubrication
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, announced today the si
5/22/17 - New Weighing Equipment Helps Pharmaceutical Company Pass the Audit Risk-Based Process Verification
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. At its Berlin site, the company runs state-of-the-art production lines. The challenge for Claudia Brostmeyer, Head of Quality Control at the Berlin site, is to ensure that all workplaces with their v
5/22/17 - PERRIGO CO PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013. We became the successor registrant to Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc, which is discussed further in Item 8. Unless the context requires otherwise, the terms "Perrigo", the "Compa
5/22/17 - Sunovion Announces Positive Results from Study Evaluating Latuda (lurasidone HCl) in Children and Adolescents with Bipolar Depression at Annual American Psychiatric Association Meeting
Sunovion Pharmaceuticals Inc. today announced that results of a Phase 3 clinical study evaluating Latuda in children and adolescents with major depressive episodes associated with bipolar I disorder showed statistically significant and clinically meaningful improvement in depressive symptoms compared to placebo. The results were presented...
5/22/17 - U.S. FDA Accepts for Review Supplemental New Drug Application for Aptiom (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 to 17 Years of Age
The expected action date by the FDA under the Prescription Drug User Fee Act is September 13, 2017. We are pleased that the FDA has accepted our supplemental New Drug Application to potentially bring a new treatment option to children and adolescents who experience partial-onset seizures, said Antony Loebel, M.D., Executive Vice President and
5/19/17 - AAP Responds to FDA Reauthorization Act of 2017 as Passed by House Subcommittee
The American Academy of Pediatrics issued the following news release:. The FDA Reauthorization Act of 2017 passed today by the U.S. House of Representatives Energy and Commerce Health Subcommittee to reauthorize U.S. Food and Drug Administration user fees is a missed opportunity for children. The House vote comes one week after the U.S. Senate Comm
5/19/17 - Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer (NSCLC)
Novartis International AG/ Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer. *Phase III trial, first-line treatment with Zykadia resulted in improved progression-free survival over SOC chemotherapy with maintenance, including in patients with brain metastases* Zykadia is...
5/19/17 - Patent Issued for Method for Treatment of Acne Using Pharmaceutical Compositions of Clindamycin and Adapalene (USPTO 9636353)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Mittal, Ravindra; Roy, Sunilendu Bhushan; Kothari, Jay Shantilal; Sheikh, Shafiq; Patel, Jitendra Dasharathlal; Pancholi, Jinesh Suresh, filed on October 19, 2011, was published online on May 2, 2017. The patent's
5/19/17 - Prescription Antiacne Drugs Market - Trends and Opportunities for the Industry by 2023
Albany, NY 05/19/2017 Prescription Antiacne Drugs Market. Acne is a common disorder that leads to formation of lesions or zits. The disease is characterized by overproduction of sebum due to high level of production of male hormone named as androgen during puberty.
5/18/17 - Avion Pharmaceuticals, LLC, Responds to First Data Bank Decision: 'Pregnant Women And Expectant Infants Will Be Compromised'
Avion Pharmaceuticals, LLC, the makers of the Prenate line of prescription prenatal vitamins, has been informed of an announcement from First Data Bank, Inc. First Data Bank is the publisher of pharmaceutical information that is used within healthcare information systems for medication decision support and negotiating reimbursement rates paid
5/18/17 - Innovus Pharma Files Its Product License Application in Canada for the Commercialization of Vesele as a Natural Health Product to Help Improve Symptoms of Sexual Dysfunction
Innovus Pharmaceuticals, Inc. today announced that the Company filed its Product License Application with Health Canada as a Natural Health Product to market its current best-selling product Vesele with the indication to Help Improve Symptoms of Sexual Dysfunction. If accepted by Health Canada, Vesele will be available over-the-counter
5/18/17 - Over-the-Counter Drug 2017 Global Market Expected to Grow at CAGR 6.19% and Forecast to 2020
OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. Get a Sample Report@ https://www.wiseguyreports.com/sample-request/605454-global-over-the-counter-drug-market-2016-2020. The market is divided into the following segments based on...
5/17/17 - AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology (ASCO) Annual Meeting
AbbVie, a global biopharmaceutical company, today announced it will present data about the company's portfolio of approved and investigational oncology medicines during the 53 rd Annual Meeting of the American Society of Clinical Oncology, June 2-6, in Chicago. "AbbVie's data presentations at this year's ASCO meeting reinforce our diverse and...
5/17/17 - VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, announces today it has entered into a Canada- wide distribution agreement for INSTI HIV-1/HIV-2 Antibody Test. "We are very pleased to have acquired the Canadian distribution rights to INSTI," commented Bob Rai, CEO.
5/17/17 - VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, announces today it has entered into a Canada- wide distribution agreement for INSTI (R) HIV-1/HIV-2 Antibody Test. "We are very pleased to have acquired the Canadian distribution rights to INSTI," commented Bob Rai, CEO.
Articles(s): 1 - 24 of 24     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415